Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Thalassemia × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 173 Neoplasms 135 Prostatic Neoplasms 94 Lung Neoplasms 76 Carcinoma, Non-Small-Cell Lung 53 Colorectal Neoplasms 52 Pancreatic Neoplasms 44 Head and Neck Neoplasms 43 Carcinoma, Hepatocellular 39 Rectal Neoplasms 38 Multiple Myeloma 37 Brain Neoplasms 36 Colonic Neoplasms 33 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Leukemia, Myeloid, Acute 30 Esophageal Neoplasms 30 Leukemia 29 Lymphoma, Non-Hodgkin 28 Lymphoma 28 Neoplasm Metastasis 27 Ovarian Neoplasms 24 Hodgkin Disease 24 Uterine Cervical Neoplasms 23 Motor Activity 23 Pain 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Glioma 20 Carcinoma, Renal Cell 20 Anxiety Disorders 20 Lymphoma, Follicular 19

Interventions

fludarabine phosphate 1 fludarabine 1 Mesna 1 Cyclophosphamide 1 Busulfan 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡